BioCentury
ARTICLE | Clinical News

Phenoxodiol regulatory update

November 8, 2004 8:00 AM UTC

FDA granted Fast Track designation to phenoxodiol, a synthetic human phenolic hormone inhibitor of various enzymes, to treat recurrent ovarian cancer. ...